tradingkey.logo

Regulus Therapeutics Inc

RGLS
8.160USD
0.000
Close 12/26, 16:00ETQuotes delayed by 15 min
540.87MMarket Cap
LossP/E TTM

Regulus Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.82
48.07%
Analyst Rating
2025-07-01

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.823, with a year-on-year change of 48.07%.

What is the net income of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its net income was -46.36M, with a year-on-year change of -54.34%.

What is the net margin of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of -100.00%.

What is the Return on Equity (ROE) of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -95.01%, with a year-on-year change of 13.86%.

What is the Return on Assets (ROA) of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -80.67%, with a year-on-year change of -4.03%.

What is the operating profit of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its operating profit was -50.04M, with a year-on-year change of -60.85%.

What are the current assets of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its current assets were 82.34M, with a year-on-year change of 192.22%.

What are the total assets of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its total assets of Regulus Therapeutics Inc were 84.18M, with a year-on-year change of 173.76%.

What are the total liabilities of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its total liabilities of Regulus Therapeutics Inc were 7.77M, with a year-on-year change of -18.72%.

What is the total equity of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its total equity of Regulus Therapeutics Inc was 76.41M, with a year-on-year change of 260.64%.

What is the net operating income of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its net operating income of Regulus Therapeutics Inc was -46.36M, with a year-on-year change of -54.34%.

What is the net investment of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its net investment of Regulus Therapeutics Inc was -35.98M, with a year-on-year change of -348.31%.

What is the net financing of Regulus Therapeutics Inc?

According to Regulus Therapeutics Inc's FY2024 earnings report, its net financing of Regulus Therapeutics Inc was 92.42M, with a year-on-year change of 682.13%.
KeyAI